| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JJCO/HYF011 |
| P698 | PubMed publication ID | 11948229 |
| P2093 | author name string | Akimasa Nakao | |
| Kenji Hibi | |||
| Katsuki Ito | |||
| Seiji Akiyama | |||
| Hideyuki Ando | |||
| Taiji Yamazaki | |||
| Kazuhiko Hidemura | |||
| P433 | issue | 2 | |
| P921 | main subject | colorectal carcinoma | Q25493920 |
| P304 | page(s) | 54-58 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | Japanese Journal of Clinical Oncology | Q2231629 |
| P1476 | title | Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma | |
| P478 | volume | 32 |
| Q91792318 | A case of stercoral colitis with marked elevation of serum carcinoembryonic antigen |
| Q41138051 | Biology of colorectal pulmonary metastasis: implications for surgical resection |
| Q24186921 | Blood CEA levels for detecting recurrent colorectal cancer |
| Q26750899 | Cell-free circulating tumor DNA in cancer |
| Q41542234 | Clinical significance of serum anti-p53 antibody expression following curative surgery for colorectal cancer |
| Q90640909 | Detection of circulating tumor cell DNA for monitoring advanced gastric cancer |
| Q39254756 | Impact of the post/preoperative serum CEA ratio on the survival of patients with rectal cancer |
| Q27010159 | Liquid biopsies: genotyping circulating tumor DNA |
| Q39279845 | Liquid biopsy: unlocking the potentials of cell-free DNA. |
| Q36614777 | New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer |
| Q83880449 | Pattern of carcinoembryonic antigen drop after laparoscopic radiofrequency ablation of liver metastasis from colorectal carcinoma |
| Q33697983 | The feasibility of using mutation detection in ctDNA to assess tumor dynamics |
| Q93185508 | The prognostic value of the postoperative serum CEA levels/preoperative serum CEA levels ratio in colorectal cancer patients with high preoperative serum CEA levels |
| Q40085419 | Tumor DNA: an emerging biomarker in head and neck cancer |
Search more.